Dynamic Technology Lab’s Neuropace NPCE Stock Holding History
Bought
Maintained
Sold
Other funds holding NPCE
PCH
SCM
FLAM
O
DCM
AC
Dynamic Technology Lab's NPCE Position: Q2 2026 in Review
Dynamic Technology Lab sold out of Neuropace (NPCE) in Q2 2026, closing a stake of 16,956 shares — an estimated $223K sold.
Dynamic Technology Lab first reported a position in NPCE in Q1 2026 and held it in 1 quarter. The position peaked at $223K in Q1 2026. 113 funds tracked by Wall St. Rank hold NPCE as of Q2 2026.
- Dynamic Technology Lab reported no remaining Neuropace position as of Q2 2026 after selling out during the quarter.
- Dynamic Technology Lab sold 16,956 Neuropace shares in Q2 2026, an estimated $223K.
- Dynamic Technology Lab first reported a position in Neuropace in Q1 2026 and held it in 1 quarter.
- Dynamic Technology Lab's Neuropace position peaked at $223K in Q1 2026.
- 113 funds tracked by Wall St. Rank held Neuropace as of Q2 2026.
Based on Dynamic Technology Lab's 13F filing for Q2 2026, filed 13 Aug 2026.